Primemd Inc.

FRC's fair value estimate for Primemd Inc., and the rating behind it. PRMD last traded at $0.0007, 0.5× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Valuation, profitability, liquidity and leverage ratios for Primemd Inc.. Starting points for Primemd Inc.: P/E 0.5, EPS $0.17, beta -7.42 — an Medical - Care Facilities name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend history, yield and payout sustainability for Primemd Inc.. Primemd Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Reported vs. expected earnings history for Primemd Inc.. Trailing twelve-month EPS for Primemd Inc. stands at $0.17. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Income statement, balance sheet and cash flow history for Primemd Inc.. Primemd Inc. has reported as a listed company since 1994. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Primemd Inc. valued side by side against its closest peers. Primemd Inc. is measured against Medical - Care Facilities peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Which institutions hold Primemd Inc., and how their positions are changing. At a $12,949 market value, institutional positions materially move Primemd Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Buying and selling by Primemd Inc. executives and directors. Shares of Primemd Inc. have traded between $0.0002 and $0.0007 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

U.S. Senate disclosures naming Primemd Inc.. Primemd Inc. is a $12,949 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

U.S. House of Representatives disclosures naming Primemd Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

Latest headlines and company announcements for Primemd Inc.. Coverage tracks Primemd Inc. within Medical - Care Facilities (Healthcare). Press releases and market coverage, newest first.